Bid & Ask: The Deals of the Week
Noteworthy expenditures of the week
This article is for subscribers only.
1. Anheuser-Busch InBev will pay $20.1 billion for the 50 percent of Grupo Modelo it doesn’t already own. It plans to make Corona Extra a global flagship brand, a status currently reserved for Budweiser.
2. After failing to get approval for a new diabetes treatment in January, Bristol-Myers Squibb will pay $5.3 billion for Amylin Pharmaceuticals, the maker of two drugs currently on the market for the disease.